New drug test aims to heal painful, Hard-to-Treat skin wounds
NCT ID NCT06563323
Summary
This study is testing whether a medication called guselkumab can help heal painful skin ulcers caused by pyoderma gangrenosum, a rare inflammatory skin condition. Seventeen adult participants will receive guselkumab injections every four weeks along with a stable daily dose of prednisone for 28 weeks, with follow-up until week 40. Researchers will measure how well the ulcers heal, whether pain improves, and how the treatment affects quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WOUND HEAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ohio State Dermatology
RECRUITINGColumbus, Ohio, 43215, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Oregon Health and Science University
NOT_YET_RECRUITINGPortland, Oregon, 97239, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.